Glaukos Analysts Boost Their Forecasts Following Better-Than-Expected Q3 Earnings
Glaukos beat Q3 estimates, raised FY26 sales guidance to $775M-$785M, and shares jumped 17.4%; analysts lifted price targets.
Share
Why It Matters
Glaukos did better than experts thought it would in Q3. Now experts think the company will make more money next year, which is a good sign.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.